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Abstract
Background—Heart failure and arrhythmias occur more frequently in patients with type 2 
diabetes (T2DM) than in the general population. T2DM is preceded by a prediabetic condition 
marked by elevated reactive oxygen species (ROS) and subclinical cardiovascular defects. 
Although multifunctional Ca2+ calmodulin-dependent protein kinase II (CaMKII) is ROS-
activated and CaMKII hyperactivity promotes cardiac diseases, a link between prediabetes and 
CaMKII in the heart is unprecedented.
Objectives—to prove the hypothesis that increased ROS and CaMKII activity contribute to heart 
failure and arrhythmogenic mechanisms in early stage diabetes.
Methods-Results—Echocardiography, electrocardiography, biochemical and intracellular Ca2+ 
(Ca2+i) determinations were performed in fructose-rich diet -induced impaired glucose tolerance, a 
prediabetes model, in rodents. Fructose-rich diet rats showed decreased contractility and 
hypertrophy associated with increased CaMKII activity, ROS production, oxidized CaMKII and 
enhanced CaMKII-dependent ryanodine receptor (RyR2) phosphorylation compared to rats fed 
with control diet. Isolated cardiomyocytes from fructose-rich diet showed increased spontaneous 
Ca2+i release events associated with spontaneous contractions, which were prevented by KN-93, a 
CaMKII inhibitor, or addition of Tempol, a ROS scavenger, to the diet. Moreover, fructose-rich 
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diet myocytes showed increased diastolic Ca2+ during the burst of spontaneous Ca2+i release 
events. Micetreated with Tempol or with sarcoplasmic reticulum-targeted CaMKII-inhibition by 
transgenic expression of the CaMKII inhibitory peptide AIP, were protected from fructose-rich 
diet-induced spontaneous Ca2+i release events, spontaneous contractions and arrhythmogenes is in 
vivo, despite ROS increases.
Conclusions—RyR2 phosphorylation by ROS-activated CaMKII, contributes to impaired 
glucose tolerance-induced arrhythmogenic mechanisms, suggesting that CaMKII inhibition could 
prevent prediabetic cardiovascular complications and/or evolution.
Keywords
arrhythmias; prediabetes; impaired glucose tolerance; CaMKII; ryanodine receptor
1. Introduction
Type 2 diabetes mellitus (T2DM) is a chronic and progressive disease that represents a 
serious Public Health problem worldwide due to its high mortality, morbidity and cost[1–3]. 
The rapid growth of T2DM is associated with high calorie diets and sedentary habits[4] of 
modern societies. In the USA the consumption of fructose rich syrups exceeds the changes 
in intake of any other food contributing to nearly 40% of the caloric intake[5]. Based on 
these records, some authors suggested that this increase in fructose consumption has 
contributed to the current epidemic of obesity and T2DM[6]. Furthermore, there is evidence 
that fructose-rich diet promotes glucooxidative stress[7]. In most cases of T2DM, metabolic 
defects precede overt clinical disease. These metabolic derangements include impaired 
glucose tolerance and impaired fasting glucose. The presence of these alterations defines the 
prediabetic state[3, 8]. Importantly, cardiovascular disease constitutes the leading cause of 
death in patients with diabetes and prediabetes[9–11]. Although the published data are 
limited, there is evidence that prediabetes and borderline diabetes associate with an 
increased risk of sudden cardiac death possibly due to cardiac arrhythmias[11, 12]. 
Moreover, increased arrhythmogenic risk is present in young people with diabetes even in 
the absence of detectable systolic dysfunction[13], suggesting that there is an early increased 
propensity to arrhythmias in T2DM. Thus, improved understanding of pro-arrhythmogenic 
mechanisms in prediabetes could lead to new approaches for preventing cardiovascular 
injury and sudden death.
Arrhythmias can be triggered by early (EADs) or delayed after depolarizations (DADs). 
EADs are membrane depolarizations that appear before action potential (AP) repolarization. 
It is generally accepted that EADs arise from current flowing through L-type Ca2+ 
channels[14]. In contrast, DADs occur following AP repolarization and have been associated 
to the higher frequency of intracellular Ca2+ Sparks (CaSp). CaSp can trigger a Ca2+-
activated transient-inward current, which is produced by the electrogenic Na+-Ca2+ 
exchanger (NCX) working in the forward mode[15].
The frequency of CaSp depends on two main factors: the sarcoplasmic reticulum (SR) Ca2+ 
load and the sensitivity of ryanodine receptor (RyR2) to Ca2+ activation[16]. RyR2 
dysregulation could result from different factors, including increases in the phosphorylation 
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at Ser2808, a validated protein kinase A (PKA) site and/or Ser2814, a validated Ca2+-
calmodulin dependent kinese II (CaMKII) site[17], redox modifications[18] and/or site 
receptor mutations[19]. In diabetes there is an increase in CaMKII activity, which has been 
associated with increased mortality after myocardial infarction[20]. However, the activity 
and potential role of CaMKII in impaired glucose tolerance has never been explored.
Fructose-rich diet is a well characterized model of impaired glucose tolerance[21]. High 
fructose diet disturbs metabolic homeostasis, increases plasma fructose, and induces 
systemic insulin resistance (IR). In the liver, fructose is metabolized into glyceraldehyde and 
dihydroxyacetone phosphate. These particular fructose end products can then readily 
converge with the glycolytic pathway. Of keyimportance is the ability of fructose to by-pass 
the main regulatory step of glycolysis, the conversion of glucose-6-phosphate to fructose 
1,6-bisphosphate, controlled by phosphofructokinase. Thus, while glucose metabolism is 
negatively regulated by phosphofructokinase, fructose can continuously enter the glycolytic 
pathway. Therefore, fructose can uncontrollably produce glucose, glycogen, lactate, and 
pyruvate, providing both the glycerol and acyl portions of acyl-glycerol molecules. These 
particular substrates, and the resultant excess energy flux due to unregulated fructose 
metabolism, will promote the overproduction of triglycerides (reviewed in [22]), which in 
turn contributes to reduced insulin sensitivity and hepatic insulin resistance/glucose 
intolerance.
Here we used the fructose rich diet model to test the hypothesis that reactive oxygen species 
(ROS) and CaMKII contribute to proarrhythmic mechanisms in prediabetes by RyR2 
hyperphoshporylation and disturbed intracellular Ca2+ homeostasis. Detection and 
recognition of the initial underling pathways that determine the arrhythmogenic substrates in 
prediabetes could enable the development of new strategies to either preventor diminish 
heart failure and arrhythmias associated with T2DM.
2. Methods
An expanded Methods section is available in the online Data Supplement.
2.1. Animals and protocols
All experiments were performed in accordance with the Guide for Care and Use of 
Laboratory Animal (NIH Publication No.85-23, revised 1996) and approved by the Ethics 
committee of the Faculty of Medicine, La Plata, Argentina). Experiments were performed in 
male Wistar rats (200 to 300g). Animals were divided into two groups: control diet and 
fructose-rich diet group which received the same diet plus 10% (W/V) fructose.
Wild type (WT) and transgenic male mice with cardiomyocyte-delimited transgenic 
expression of SR-targeted CaMKII inhibitor AIP (SR-AIP)[23], were divided into three 
groups: 1- control group; 2- fructose group (10% w/v fructose); and 3-Fructose+Tempol 
(10% w/v fructose plus 0.8 mM 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl). Tempol, 
was used as antioxidant. All treatments were performed for three weeks in the drinking 
water.
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2.2. Plasma determinations
Blood samples were used to assess plasma glucose level and intraperitoneal tolerance test to 
glucose. Triglyceride (commercial kit) and insulin plasma (RIA) levels were also assessed. 
Insulin resistance was assessed with the HOMA-IR index, calculated as insulin (µU/ml) x 
glucose (mmol/L)/22.5[24].
A significant difference on the area under the curve of the intraperitoneal tolerance test to 
glucose between control diet and fructose rich diet animals was considered an impaired 
glucose tolerance status.
2.3. Echocardiographic Examination
Echocardiogram was performed in rats under light anesthesia (35 mg/kg sodium 
pentobarbital ip).
2.4. Electrocardiogram
Surface ECG were recorded in mice without anesthesia, for 30 min, using standard ECG 
electrodes (lead I) and a Power Lab 4ST data acquisition system. A catecholamine challenge 
[caffeine and epinephrine, 120 mg/kg and 1.6 mg/Kg,], was applied to unmask the presence 
of arrhythmias under stress conditions. Ventricular ectopic beats (premature or ventricular 
escape beats), ventricular fibrillation and ventricular tachycardia were quantifying during the 
recording period.
2.5. Myocyte Isolation
Before the sacrifice, the anesthetic and analgesic drugs used were 75mg/Kg of ketamine and 
5mg/Kg of diazepam, respectively. The plane three of phase III of anesthesia was verified by 
loss of corneal reflex and the appearance of slow deep diaphragmatic breathing. Myocytes 
were isolated by enzymatic digestion as previously described[25].
2.6. Ca2+i and Cell Shortening
Rat cardiac isolated myocytes were loaded with Fura-2/AM and Ca2+i fluorescence, was 
measured in an IonOptix setup (Milton, MA). SR Ca2+ load was assessed with a caffeine 
pulse (25 mM). Fluorescence data were stored for an off-line analysis (ION WIZARD 
fluorescence analysis software).
2.7. Confocal imaging of intact cardiac myocytes
Confocal images of Ca2+ in cells loaded with Fluo-3AM were taken in line scan mode to 
assess Ca2+ transients, sparks, waves and spontaneous contractile activity. Sparks and waves 
were analyzed in quiescent cells and after 5 min stimulation at 0.5 Hz.
2.8. ROS Determinations
Superoxide Anion (·O2−) Production—Anion superoxide (·O2−) production was 
measured in cardiac tissue slices from the left ventricle after 20 min incubation with 
lucigenin (Bis-N-metilacridinium) 5 µmol/L- enhanced chemiluminescence method, in a 
luminometer (Chameleon, Hidex).
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Lipid Peroxidation—Lipid peroxidation was determined by measuring the rate of 
production of thiobarbituric acid reactive substances (TBARS), expressed as nmol/mg 
protein.
2.9. Western Blot
Hearts were freeze-clamped, pulverized and homogenized. Protein was measured by the 
Bradford method using BSA as standard. Lysates were subjected to SDS-PAGE[26]. After 
western-blotting, membranes were probed overnight with specific antibodies.
2.10. Statistics
Continuous variables were expressed as mean ± SEM and were evaluated with either 
unpaired Student t test or ANOVA followed by Tukey’s Post Hoc test, when comparison 
among different groups was performed. Spontaneous Ca2+ release events were expressed as 
nonparametric continuous data (individual data in values plots). Whenever the distribution 
was skewed, the Mann-Whitney test was used to compare these data. A p value <0.05 was 
considered significant.
3. Results
3.1. Characterization of fructose-rich diet model
Fructose-rich diet animals showed increased serum levels of insulin, triglycerides, non-
esterified fatty acids (NEFA) levels, the area under the curve of serum glucose after the 
intraperitoneal glucose administration and insulin resistance, as shown by the higher values 
of the homeostatic model assessment(HOMA-IR[24]), compared to control diet rats (Table 
S1). These data are consistent with an insulin-resistance pattern. In contrast, fasting glucose 
levels and body weights were similar in control diet and fructose-rich diet rats, indicating a 
prediabetic state rather than an established T2DM. Table S2 depicts the food, water and 
caloric intake in both groups of rats.
Prediabetic fructose-rich diet rats have cardiac hypertrophy and systolic dysfunction as 
shown in Table S3 and Fig 1. Systolic blood pressure was similar (p=0.70) in control 
diet(118±2 mmHg) and fructose-rich diet rats (115±4 mm Hg), indicating that alterations of 
cardiac structure and function in fructose-rich diet rats were independent of blood pressure.
3.2. Fructose-rich diet increases spontaneous Ca2+i release events
The findings observed at the whole animal level, prompted us to study whether Ca2+ 
handling was altered at the cellular level. The protocol to study myocardial Ca2+i handling is 
depicted in Fig 2A.
Under non-stressed conditions (without Isoproterenol, Iso), cardiomyocytes isolated from 
fructose-rich diet rats showed a significantly higher number of spontaneous Ca2+i release 
events (Fig 2A-D) that correlated with spontaneous contractions (Fig. S1) associated with a 
shorter latency period (Fig 2E) compared to control dietmyocytes. Of note, fructose-rich diet 
but not control diet myocytes showed dyssynchronous Ca2+ release events between paced 
beats (Fig 2B-C). I so enhanced the number of spontaneous Ca2+i release events (Fig 2D) 
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and decreased the latency period (Fig 2E). These findings suggest that fructose-rich diet rats 
have defective, proarrhythmic Ca2+i handling patterns.
We next used confocal microscopy to measure local SR Ca2+ release events (CaSp) and 
Ca2+ waves in intact isolated rat cardiomyocytes under the same experimental protocol 
conditions of Fig 2A. At baseline, CaSp frequency, width (FWHM) and amplitude were not 
different between cardiomyocytes isolated from fructose-rich diet or control diet rats. In 
contrast, fructose-rich diet cardiomyocytes showed significantly increased Ca2+ wave 
frequency and spontaneous contractions compared to control diet myocytes (Fig 3A-B, and 
Table S3). I so did not affect CaSp frequency in control diet or fructose-rich diet cells, but 
significantly increased wave frequency and spontaneous contractions in fructose-rich diet 
cardiomyocytes (Fig 3A-B). These results suggest that the increase in Ca2+iwave frequency 
in fructose-rich diet hearts was sufficient to trigger spontaneous contractile activity, and that 
myocardial defects in rats with fructose-rich diet-induced prediabetic state are a 
consequence of a loss of Ca2+i homeostasis.
3.3. CaMKII mediates spontaneous Ca2+i release events in prediabetic cardiomyocytes
CaMKII over-expression and hyperactivation enhances SR Ca2+ leak, which can serve as a 
molecular trigger for arrhythmias[27–29]. To investigate a possible role of CaMKII in 
fructose-rich diet-induced spontaneous activity, we first asked if CaMKII was activated in 
hearts from fructose-rich diet animals. Fig 4A, shows that a constitutively active, auto 
phosphorylated form of CaMKII (P-CaMKII)[30] and phosphorylation of a CaMKII-
catalyzed target site on phospholamban (PLN), Thr17[26], were increased in fructose-rich 
diet compared to control rat hearts, with no changes in total proteins expression. In a second 
group of experiments, we aimed to determine whether spontaneous Ca2+i release events in 
myocytes from fructose-rich diet rat hearts could be prevented or reduced in the presence of 
an experimental CaMKII inhibitor, KN-93. Fig 4B-C shows that KN-93preventedthe 
increase in spontaneous Ca2+i release events and spontaneous contractions in 
cardiomyocytes from fructose-rich diet rats under basal and I so-stimulated conditions. In 
contrast, KN-92, an inactive an a log of KN-93, failed to prevent spontaneous Ca2+i release 
events in these cardiomyocytes.
3.4. Mechanisms of CaMKII-induced spontaneous Ca2+i release events and contractile 
activity in prediabetic hearts
Because CaSp and Ca2+i waves can occur due to SR Ca2+ overload[16] or as a consequence 
of an alteration in the function of RyR2[31], we performed studies to determine how these 
mechanisms could contribute to the generation of increased Ca2+i waves. It was found that 
caffeine induced Ca2+i transients (CaiT) were significantly decreased in fructose-rich diet 
with respect to control diet cells (Fig 5), which is in line with the increase in SR Ca2+ leak in 
LV cardiomyocytes (Fig 3). Of note, the decrease in SR Ca2+ content occurs in fructose-rich 
diet myocytes in spite of the increase in SERCA2a activity (Fig 5B, lower panel), which 
would tend to increase SR Ca2+ load. This increase, which may be due to the CaMKII-
dependent increase in Thr17 phosphorylation of PLN, would contribute to avoid a further 
decrease in SR Ca2+ load. Moreover, although, diastolic Ca2+ did not change in steady state 
conditions (Fig 5B, middle panel), it greatly increases when spontaneous Ca2+i release 
Sommese et al. Page 6
Int J Cardiol. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
events occur (Fig S2 and see below). Thus, diastolic Ca2+ during spontaneous Ca2+i release 
events was greatly increased in fructose-rich diet than in control diet rats(Fig 5B middle 
panel, stripped bars). Moreover, the amplitude of stimulated CaiT was similar between 
control diet and fructose-rich diet animals. This indicates that fractional Ca2+ release (ratio 
of twitch/caffeine-induced Ca2+ transient), was significantly increased in fructose-rich diet 
with respect to control diet cells, as shown in Fig 5A-B. Together the results suggest that the 
increase in spontaneous activity- as well as the enhanced fractional Ca2+ release-, is 
associated to an alteration of RyR2 rather than to SR Ca2+ overload.
Notably, cell shortening showed a significant increase in fructose-rich diet vs. control diet 
myocytes, in spite of the similar CaiT, a finding that is in line with an increase in 
myofilament Ca2+ sensitivity, as previously described[32]. This finding is in contrast to the 
ones obtained in the echocardiographic studies, where a systolic dysfunction was observed 
(Fig 1 and Table S1). The cause for the discrepancy is not apparent to us and requires further 
investigation. Possible explanations to these findings are alterations at the tissue and whole 
organ level (i.e, interstitial fibrosis, apoptosis, vascular compromise), which we did not 
assess in this study and are not present in isolated myocytes. For instance, sustained 
hyperglycemia may increase glycation of interstitial proteins such as collagen, which results 
in myocardial stiffness and impaired contractility[33, 34].
Since it has been shown that CaMKII-dependent phosphorylation of RyR2 increases SR 
Ca2+ leak, CaSpF and arrhythmias[35], we next sought to examine the phosphorylation 
status of RyR2. Fig 5C shows that there is an increase in RyR2 Ser2814 phosphorylation in 
fructose-rich diet relative to control diet rats without changes in RyR2 expression. In 
contrast, phosphorylation of a PKA-catalyzed phosphorylation site, Ser2808, was not altered 
in prediabetic compared with control hearts. Interestingly, the enhanced fractional SR Ca2+ 
release observed in fructose-rich diet cardiomyocytes supports the notion that RyR2 
phosphorylation at Ser2814 site activates both diastolic and systolic RyR2 Ca2+ release[36, 
37].
Taken together, our results are consistent with a concept where the presence of a 
proarrhythmogenic substrate is underlying by CaMKII phosphorylation of RyR2 in fructose-
rich diet rats.
3.5. Mechanism of CaMKII activation and RyR2 destabilization
CaMKII is activated by an increase in Ca2+/calmodulin. As mentioned above, there was a 
significant increase in spontaneous Ca2+i release events in fructose-rich diet rats with 
respects to control animals, both with or without electrical stimulation. Spontaneous Ca2+i 
release events usually appear as a burst of spontaneous events associated with an increase in 
diastolic Ca2+ (See Fig 5B, middle panel, stripped bar). Fig S1 shows a typical example of a 
burst of spontaneous Ca2+i release events in fructose-rich diet rats associated with the 
increase in diastolic and systolic Ca2+. In contrast, spontaneous Ca2+i release events are 
sporadic in control diet animals and failed to significantly increase diastolic Ca2+. Moreover, 
the increase in cytosolic Ca2+ that occurred during spontaneous Ca2+i release events, -
estimated by the integral of these events during the 3 min period prior to electrical 
stimulation-, was also significantly increased by 3.14 ± 1.4 % (p< 0.05). Taken together the 
Sommese et al. Page 7
Int J Cardiol. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
results reveal a temporary increase in intracellular Ca2+ in fructose-rich diet rat myocytes 
with respect to cells of non-treated animals. Moreover, previous experiments have 
demonstrated that CaMKII can maintain its activity by ROS[38], even at sub diastolic Ca2+ 
levels[25] and that ROS-induced arrhythmias were linked to the ability of ROS to activate 
CaMKII[39]. Thus, we tested the possibility that an increase in ROS production may 
contribute to the increased in CaMKII sustained activity of fructose-rich diet myocytes. Fig 
6A-B shows that lipid peroxidation (determined by TBARS) and ROS production (O2−) 
were significantly enhanced in fructose-rich diet animals. We next measured oxidized 
CaMKII (ox-CaMKII) in fructose-rich and control diet rats. Fig 6C depicts typical western 
blots and overall results showing that the hypothesized increase in ox-CaMKII, indeed 
occurred. These results indicate that ROS production and ox-CaMKII are enhanced in 
fructose treated animals, confirming the possibility that ROS contributes to CaMKII activity 
in fructose-rich diet myocytes.
To further investigate the possible role of ROS and CaMKII in the arrhythmogenic pattern 
observed in the fructose-rich diet model, we next examined fructose-rich and control diet 
WT and SR-AIP transgenic mice, as a genetic tool to confirm the results obtained in rat. SR-
AIP mice have myocardial-delimited transgenic expression of the CaMKII inhibitory 
peptide AIP targeted to SR membranes by fusion with the PLN transmembrane domain[23]. 
As shown in the Table S1, fructose-rich diet WT and SR-AIP mice present significant 
increases in the area under the curve of the intraperitoneal tolerance test to glucose, 
indicating a prediabetic condition similar to fructose-rich diet rats. Fig 7A shows that 
fructose-rich diet WT mice had significantly (p=0.02) increased oxidative stress (TBARS) 
compared to control diet mice. To explore the possible participation of ROS in the 
spontaneous Ca2+i release activity evoked by fructose treatment in WT mice we used WT 
fructose-rich diet mice treated with the intracellular ROS scavenger Tempol. Co-treatment of 
WT fructose-rich diet mice with Tempol prevented the increase in TBARS and in CaMKII 
phosphorylation of RyR2 (Fig 7A-B). Moreover, the spontaneous events produced by 
fructose treatment were also prevented by Tempol (Fig 7C-D). Taking together the results 
suggest that ROS are involved in the spontaneous activity of fructose-rich diet animals 
through CaMKII-dependent phosphorylation of RyR2. To further explore this point, we 
performed experiments in mice with CaMKII inhibition at the SR level (SR-AIP mice). Fig 
7E shows that SR-AIP fructose-rich diet mice had also a significant increase in oxidative 
stress compared to SR-AIP control diet mice (p<0.05), which was prevented by co-treatment 
with Tempol. Tempol treatment also significantly decreased ox-CaMKII in SR-AIP mice 
treated with fructose-rich diet to 75.04±7.34 %. However, these mice did not exhibit neither 
CaMKII-RyR2 phosphorylation nor spontaneous Ca2+ release events, either in the absence 
or presence of Tempol (Fig 7F-H). Lastly, we performed an additional series of experiments 
in isolated myocytes previously treated with H2O2 in the presence and absence of KN-93. It 
was found that the CaMKII inhibitor was able to prevent the arrhythmic events observed in 
the presence of H2O2 (Fig S3). Taken together, these results indicate that the increase in 
oxidative stress is an upstream event in a pathway that leads to oxidative CaMKII activation 
and proarrhythmic changes in Ca2+i handing induced by fructose treatment.
Finally, we performed electrocardiography (ECG) in the conscious intact animal for 30 min 
and measured spontaneous Ca2+i release events and spontaneous contractions in 
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cardiomyocytes by confocal microscopy. WT littermate control diet mice showed normal 
sinus rhythm, evidenced from continuous in vivo ECG measurements, opposite to fructose-
rich diet WT mice which showed significant bradycardia (Table S4A and Fig 8Ai-ii). 
Moreover, fructose-rich diet WT mice transiently exhibited at least one of the following 
ECG alterations, AF, AV block, bidirectional ventricular tachycardia, ventricular ectopic 
beats, sustained ventricular tachycardia and ventricular fibrillation after caffeine + 
epinephrine challenge (Table S4B and Fig 8Aiii-v). All these arrhythmic events, were absent 
in fructose-rich diet WT co-treated with Tempol (Table S4B) and in fructose-rich diet-SR-
AIP mice (Fig 8B). Fig 8C-E and Table S3 show that fructose-rich diet WT mice presented a 
significantly higher CaSpF, Ca2+i waves and spontaneous contraction activity than control 
diet WT, SR-AIP and fructose-rich diet SR-AIP mice. Taken together, these results indicate 
that CaMKII actions at the SR are likely to contribute to the arrhythmic pattern observed in 
prediabetic mice.
4. Discussion
The prevalence of impaired glucose tolerance is growing worldwide[40] with the consequent 
increase in the risk of developing T2DM and cardiovascular disease. Impaired glucose 
tolerance has been shown to be a precursor of diabetes and usually coexist with an insulin 
resistance state, with higher risk for cardiovascular morbidity and mortality. The present 
results showed that ventricular myocytes from fructose-rich diet animals develop cardiac 
arrhythmogenic events. Our results indicate that CaMKII-dependent phosphorylation of 
RyR2 is a mechanism underlying the proarrhythmogenic pattern observed at the cellular 
level in fructose-rich diet rats and mice. Moreover, the enhanced activity of CaMKII 
observed in fructose-rich diet animals is mainly reliant on an increase on the oxidative stress 
produced by fructose-rich diet. To the best of our knowledge, this is the first report showing 
the presence of CaMKII-dependent proarrhythmic mechanisms in a prediabetic model.
4.1. Fructose-rich diet: the prediabetes model
The American Diabetes Association indicates that T2DM is usually preceded by a metabolic 
disorder, known as prediabetes[3]. This stage is characterized by elevated plasma glucose, 
which does not reach levels observed in diabetic subjects. Prediabetes can be diagnosed by 
simple blood tests that reveal an impaired glucose tolerance and/or impaired fasting glucose 
and/or elevated glycated haemoglobin (HbA1c), and it is thought to constitute a major risk 
factor for developing diabetes and/or other adverse outcomes like retinopathy or 
cardiovascular illness[8, 41]. Indeed, the increased risk of cardiovascular disease in people 
with impaired glucose tolerance was early recognized by the World Health Organization 
(WHO)[42].
Administration of a fructose-rich diet to normal rats for 3 weeks induces multiple abnormal 
changes in glucose (impaired glucose tolerance) and lipid metabolism, endocrine 
dysfunction, insulin resistance and increased in oxidative stress markers[21, 43, 44]. All 
these changes resemble those recorded in people with T2DM/prediabetes, supporting the 
view that fructose-rich diet is a useful model to test disease mechanisms relevant to 
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prediabetes. Indeed, fructose-rich diet model has been previously used by several authors to 
asses myocardial function[32, 45].
We successfully extended the fructose-rich diet model from rats to mice, which reproduce 
the abnormal intraperitoneal tolerance test to glucose and the frequency of spontaneous 
Ca2+i release events observed in rats. The use of fructose-rich diet in mice has the potential 
to capture the strengths inherent in genetically modified animals for mapping pathways and 
understanding disease mechanisms
4.2. Fructose-rich diet promoted spontaneous Ca2+i release events and spontaneous 
contractions
Increased risk of sudden death has been described in prediabetes and borderline diabetes[11, 
12], and enhanced arrhythmogenic risk has been detected in young people with diabetes[13]. 
Nordin et al.[46], further showed an increase in DADs propensity in streptozotocin-diabetic 
rats and it is known that diabetic patients show several ECG alterations[47, 48]. Moreover, 
abnormal glucose metabolism and impaired fasting glucose were associated with an 
increased incidence of atrial fibrillation (AF)[49]. However and as far as we know, the 
possibility that this prediabetic condition may also predispose to ventricular arrhythmias has 
never been explored. In our model of impaired glucose tolerance we have shown an increase 
in the occurrence of spontaneous Ca2+i release events, including SR CaSp and waves which 
culminates in spontaneous contractions in ventricular myocytes. In addition, we have found 
ECG abnormalities, including episodes of AF, spontaneous ventricular beats and ventricular 
arrhythmias in vivo. Therefore the current results revealed that in fructose-rich diet animals, 
the presence of an arrhythmogenic substrate is evident well before the development of 
T2DM. Moreover, catecholamine stress produced an increase in spontaneous Ca2+i release 
events in LV cardiomyocytes that appears to be substantially dependent on the elevated 
CaMKII activity.
4.3. The arrhythmogenic pattern of fructose-rich diet animals is due to an increase in 
CaMKII-dependent phosphorylation of RyR2
Multiple studies have shown that abnormal SR Ca2+ handling plays a central role in the 
initiation and/or maintenance of atrial and ventricular arrhythmias in animals and 
humans[28, 50]. Defective Ca2+i handling predisposes to spontaneous, non-synchronized SR 
Ca2+ release, which in turn activates a transient inward current that is largely carried by the 
NCX[15] and is the dominant inward current triggering DADs[51]. Moreover, CaMKII-
dependent phosphorylation of RyR2 increases SR Ca2+ leak and the susceptibility to cardiac 
arrhythmias has been described in a number of models[28, 52], suggesting that CaMKII 
inhibition could shield against proarrhythmic conditions in a variety of diseases marked by 
elevated ROS and disturbed Ca2+i. The present results showed an increase in Ca2+i sparks, 
waves and spontaneous contractions in fructose-rich diet animals. This increase occurred in 
the absence of an increment in SR Ca2+ content and was inhibited by CaMKII inhibition 
genetically targeted to the SR. These results suggest that CaMKII-dependent RyR2 
phosphorylation is a critical mediator of the increased proarrhythmogenic events in the 
fructose-rich diet-induced prediabetic-model. Of note, CaMKII-dependent phosphorylation 
of Thr17 site of PLN is increased in fructose-rich diet hearts. This should at least partially 
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explain the increase in SERCA2a activity that we detected in our experiments and could 
have stimulatory effects on SR Ca2+ leak by increasing SR Ca2+ load. Although SR Ca2+ 
load is actually lower in fructose-rich diet vs. control diet rats, our results cannot rule out the 
possibility that an increase in CaMKII-dependent PLN phosphorylation may contribute to 
maintain SR Ca2+ leak.
In conflict with the present results, Nishio et al.[53] suggested that CaMKII is upstream 
ROS generation in a model of streptozotozin diabetic rats. Whether the different models 
studied or the different stages at which the illness was appraised can explain this 
discrepancy, is not apparent from the present results and further studies are required to 
explain these differences. We demonstrated that prediabetic SR-AIP mice, which showed an 
increase in lipid peroxidation, reflecting the increase oxidative stress, are protected against 
spontaneous Ca2+i release events and ECG alterations. These results clearly indicate that 
ROS generation is upstream CaMKII activation.
4.4. Possible Mechanisms Underlying CaMKII Activation
CaMKII is initially activated by Ca2+/CaM binding. Sustained increases in Ca2+/CaM 
produce Thr287 autophosphorylation. Phosphorylated CaMKII increases the binding affinity 
for Ca2+/CaM and is able to retain residual Ca2+/CaM-independent activity. Our results 
demonstrated that the steady state diastolic Ca2+ and CaiT did not increase in fructose-rich 
diet animals. Diastolic Ca2+ only raised during the brief spontaneous Ca2+i release events 
which represents a rather temporary change. It therefore seems that raised Ca2+ is a less 
likely source/cause of chronically activated CaMKII in fructose-rich diet rats. CaMKII is 
also oxidized at Met281/282. Oxidation of CaMKII induces a similar Ca2+/CaM-independent 
form of the enzyme[38]. Interestingly, ox-CaMKII resets the Ca2+ sensitivity of CaMKII in 
such a way that very low levels of Ca2+i are sufficient for activation[25], suggesting that 
conditions of high ROS production may lead to increased CaMKII activity even without 
important changes in the levels of Ca2+/CaM. Thus, our findings strongly suggest that the 
main source of chronic CaMKII activation in fructose-rich diet rats is the enhancement of 
ROS production. Although previous studies from Nishio et al.[53] showed that CaMKII 
activation was responsible for ROS generation in overt diabetes, the present work does not 
support a CaMKII-induced ROS generation, at least in the prediabetic state. The recently 
described O-GlcNAcylation or nitric oxide-dependent activation of CaMKII[54, 55] were 
out of the scope of this study. Further investigation is needed to establish whether these 
pathways also contribute to the fructose-rich diet phenotype. Although these pathways of 
CaMKII activation would be present in our model, preventing ROS increases with Tempol 
was sufficient to avoid Ca2+ sparks and waves, which potentially culminates in cardiac 
arrhythmias. Thus in our study O-GlcNAcylation and nitric oxide-dependent activation of 
CaMKII, if present, seem to be a minor source of activation for CaMKII vs. that provided by 
oxidation.
4.5. Cardiac hypertrophy in prediabetic rats
It has been previously described that diabetic animals and humans may develop 
cardiomyopathy and hypertrophy[56–60]. The pathogenesis of these cardiac alterations is far 
from being clear and multifactorial mechanisms were proposed, including autonomic 
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dysfunction, metabolic derangements and decreased of the energetic state, abnormalities in 
ion homeostasis, alteration in structural proteins and interstitial fibrosis. To the best of our 
knowledge, this is the first report showing that fructose treatment produces hypertrophy in 
rats. Although it was not the goal of the present study to investigate the mechanisms of 
hypertrophy in these animals, it is known that in cardiac hypertrophy and heart failure, 
disturbed intracellular Ca2+ handling is involved in contractile dysfunction and contributes 
to DAD-related arrhythmias[61–63]. An important question that therefore arises from the 
present study is whether the ECG alterations of fructose-rich diet rat hearts are the 
consequence of the hypertrophy observed in these hearts. The present results cannot either 
deny or support this possibility. Our study showed that Ca2+ handling was altered and 
intracellular Na+ was increased in fructose-rich diet rats, similar to what has been described 
in different models of hypertrophy[62, 64, 65]. It is therefore possible that alterations that 
are at the basis of arrhythmias in fructose-rich diet hearts, are also involved in the 
development of hypertrophy. Moreover, although assessment of energetic metabolism of 
fructose-rich diet hearts was out of the scope of this work, it has been shown that diabetes-
induced metabolic changes decrease cardiac efficiency and energetics in both humans and 
animal models of diabetes[66]. Notably, a decrease of the energetic state of the fructose-rich 
diet hearts could also contribute to the development of cardiac hypertrophy in this model.
In summary, we have described for the first time a proarrhythmic pathway activated in the 
prediabetic condition. Here we presented new evidence showing the vulnerability of 
prediabetes to induce a ROS-dependent increase in CaMKII activity, which in turn produces 
enhanced RyR2 phosphorylation and SR Ca2+ leak capable of induces contractile activity. 
Thus, therapeutic strategies to decrease CaMKII activation may contribute to prevent or 
reduce the arrhymogenic pattern of prediabetes.
4.6. Clinical Relevance and Potential Limitations
A major challenge of T2DM is the recognition of the initial prediabetic stage to prevent its 
evolution and associated complications. The insidious beginning of T2DM includes a 
prolonged, subclinical prediabetic phase. In an animal model of prediabetes, we showed a 
striking propensity to ECG alterations. The finding that CaMKII is hyperactive in diabetic 
patients and the well-known increase in RyR2 Ca2+-leak in clinical arrhythmias[20, 29, 37] 
argue for the possible clinical relevance of our work. These findings further suggest that 
prediabetes should motivate a careful search for arrhythmias. A possible limitation of our 
model is that the caloric intake in fructose-rich diet rats is slightly but significantly higher 
when compared to control diet rats. Whether this increased caloric intake has some 
modulatory role on CaMKII activity, myocardial remodelling and arrhythmogenes is 
described here, cannot be ascertain from the present results and deserves further 
investigation. However, the fact that similar results were obtained in mice in which the 
caloric intake was similar between fructose-rich diet and control diet animals, argues against 
this possibility. Moreover, it has been previously shown that phosphorylation of CaMKII 
was not affected by changes in caloric intake[67].
We are aware however, of the limitations of any animal model to mimicking prediabetes in 
humans and therefore extrapolation of our findings to the clinical setting should be very 
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cautious. Moreover, the mechanistic link between prediabetes, cardiac arrhythmias and 
RyR2 dysfunction and Ca2+ leak in patients is unknown and requires extensive work in 
subsequent studies. Moreover, multiple possible complex processes (CaMKII activation, 
ROS signaling, etc.) may contribute to the genesis of myocardial defects in prediabetic 
individuals. Further experimental and translational studies are needed to evaluate the 
possibility that CaMKII-dependent SR Ca2+ leak may also constitute a core mechanism in 
the development and progression of ventricular arrhythmias in prediabetic patients.
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AF Atrial Fibrillation
AV Atrioventricular
Ca2+i Intracellular Calcium
CaiT Intracellular Calcium Transient
CaMKII Ca2+ Calmodulin dependent protein kinase
CaSp Calcium Sparks
CaW Calcium Waves
DAD Delay after depolarizations
EAD Early after depolarizations
ECG Electrocardiogram
LV Left ventricle
RyR2 Ryanodine Receptor 2
PLN Phospholamban
NCX Sodium-Ca2+ exchanger
ROS Reactive Oxygen Species
SR Sarcoplasmic Reticulum
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Figure 1. Structural, functional and electrical alterations in the Fructose-rich diet rat model
A, representative echocardiographic left ventricle images from control diet (CD) and 
Fructose-rich diet (FRD) treated rats; B, Hypertrophy assessed by left ventricular mass index 
(LVMI) and heart weigh/tibial length ratio (HW/TL); C, Dilation evaluated by left ventricle 
diastolic diameter (LVDD) and left ventricle systolic diameter (LVSD); D, Percent of 
endocardial shortening. The diastolic and systolic left ventricular (LV) diameters were 
increased in fructose-rich diet compared to control diet rat hearts, in association with 
significant increases in hypertrophy indices. Moreover, systolic function was reduced in 
fructose-rich diet with respect to control diet rats. Bar data are mean ± SEM. n=6 to 8 rats 
per group, *p<0.05, ***p<0.001 with respect to CD.
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Figure 2. SCRE are increased in myocytes from FRD vs CD rats
A, Protocol followed to study Ca2+i in myocytes from CD and FRD rats. Ca2+i transient 
were recorded under quiescent condition (a and c) and at 1Hz field electrical stimulation (b 
and d) in the absence and presence of Isoproterenol (Iso). A Caffeine pulse (caff) was 
performed to evaluate sarcoplasmic reticulum Ca2+ content. B, CD and C FRD myocytes. 
CaiT at the times indicated by letters a-d in panel A, in an expanded scale. Arrows indicate 
SCRE. D, Value plots of the frequency of SCRE at 0 Hz and 1 Hz normalized by the SR 
Ca2+ content, in the presence and absence of Iso. E, Latency of SCRE. Myocytes from FRD 
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rats showed a significant increase in SCRE vs. CD in all conditions tested. n= 25 to 40 
myocytes from 4–6 rats per group, *p<0.05, **p<0.01, ***p<0.001 vs. CD without Iso; § 
p<0.05 vs. CD with Iso.
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Figure 3. Local SR Ca2+ release events are increased in myocytes from FRD vs. CD rats
A, Line scan images from myocytes of CD and FRD rats in the presence and absence of 
Isoproterenol (Iso), with their respective plot profiles. B, average values of CaSpF, Wave F 
and SC frequency. FRD cardiomyocytes showed a significantly increased Ca2+ Wave F and 
SC compared to CD myocytes. Bar data are mean ± SEM. n= 20 to 26 myocytes from 4 rats 
per group, *p<0.05 compared with CD, § p<0.05 compared with CD+Iso.
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Figure 4. Inhibition of CaMKII activity prevents Spontaneous Ca2+ release events (SCRE) in 
fructose-rich diet (FRD) myocytes
A, Representative inmunoblots of PCaMKII, total CaMKII, PThr17, total PLN, SERCA2a 
and GAPDH as loading control on the left. Average of CaMKII expression and activity, 
SERCA2a expression and PLN expression and CaMKII-dependent phosphorylation of 
control diet (CD) and FRD rat hearts, on the right. B, Typical continuous recordings of Ca2+i 
transients from rat myocytes perfused in the presence of KN-92 and KN-93. Below, CaiT in 
an expanded scale at the times indicated by letters a-d. Arrows indicate SCRE.C, Value plots 
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of the frequency of SCRE at 0 Hz and 1 Hz normalized by the SR Ca2+ content, in the 
presence and absence of isoproterenol (Iso), of myocytes incubated with KN-92 and KN-93. 
CaMKII activity increased in FRD vs. CD rat hearts and CaMKII inhibition prevented the 
increase of SCRE in FRD under basal and Iso conditions. Data of inmunoblots are mean ± 
SEM. n= 10 to 17 myocytes from 3 rats per group. *p<0.05 compared with CD, § p<0.05 
compared with CD+Iso.
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Figure 5. Fructose treatment increases CaMKII-dependent phosphorylation of RyR2 and 
decreases SR Ca2+ content
A, Representative individual twitch contractions, Ca2+ transients (CaiT) and caffeine induced 
CaiT of control and fructose-rich diet (CD and FRD) rat myocytes. B, average values of cell 
shortening, CaiT amplitude, diastolic Ca2+, fractional Ca2+ release, rate constant of CaiT 
decay (1/τ of CaiT), caffeine induced CaiT amplitude, τ of caffeine induced CaiT and 
SERCA2a activity (K SERCA2a), of myocytes from CD and FRD rats. Data are mean ± 
SEM. n= 25 to 40 myocytes from 4–6 rats per group. The stripped bar in the middle panel 
represents the increase in diastolic Ca2+ that occurs during the episodes of spontaneous Ca2+ 
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release in FRD myocytes. Data are mean ± SEM of the average diastolic Ca2+ from the 
multiple spontaneous release events of each cardiac myocyte. n=18 myocytes from 6 rats. 
*p<0.05 compared with CD. C, Representative inmunoblots and average results of total 
RyR2 (on the left), PSer2814 residue of RyR2 (on the middle) and PSer2808 (on the right). β-
actin was used as loading control. Data are mean ± SEM. n= 4 rats per group, *p<0.05 
compared with CD.
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Figure 6. Lipid peroxidation, ROS production and ox-CaMKII are enhanced in FRD vs. CD 
animals
A, average data for lipid peroxidation measured by TBARS; B, ROS assessed by 
chemiluminescence; and C, representative inmunoblots and average data for oxidized 
CaMKII (ox-CaMKII) and total CaMKII from CD and FRD treated rats. Data are mean ± 
SEM. n= 4 rats per group, *p<0.05.
Sommese et al. Page 26
Int J Cardiol. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 7. Role of ROS in spontaneous Ca2+ release events and in CaMKII activation
A, Lipid peroxidation increased in fructose-rich diet (FRD) WT with respect to control diet 
(CD) mice. B, CaMKII-dependent phosphorylation of RyR2 at Ser2814 site in the presence 
and absence of Tempol. C, Line scan images of myocytes from FRD and FRD + Tempol 
(FRD+T) treated WT mice. Below the images, are depicted their respective plot profiles. 
Tempol prevented the increased spontaneous Ca2+ release events produced by fructose 
treatment.D, Average values for CaSpF, Wave F, spontaneous contractions (SC) frequency. 
E, lipid peroxidation in CD and FRD SR-AIP mice. F, CaMKII-dependent phosphorylation 
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of RyR2 at Ser2814 site in the presence and absence of Tempol in SR-AIP mice. G, Line scan 
images and their respective plot profiles from myocytes of FRD and FRD + Tempol (FRD
+T) treated SR-AIP mice. H, average values for CaSpF, Wave F and SC frequency. SR-AIP 
mice do not show any intracellular Ca2+ release event, in spite of the increase in ROS. Of 
note, values of CaSpF, Wave F and SC in either FRD or CD mice, are close to 0 (compare 
with panel D). Data are mean ± SEM. n= 10 to 15 myocytes from 4 mice per group.
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Figure 8. FRD induces cardiac arrhythmias and Local SR Ca2+ release events in WT but not in 
SR-AIP mice
A, and B, representative ECG records from CD and FRD treated WT and SR-AIP mice. A, 
normal sinus rhythm in CD WT mice (i), FRD WT mice with bradycardia (ii), bidirectional 
tachycardia (iii), ventricular ectopic beats (iv, arrow) and AV block (v, arrow). B, regular 
sinus rhythm in CD (i) and FRD (ii) SR-AIP mice. n=3 to 5 mice per group. C and D, Line 
scan images from myocytes of CD and FRD WT and SR-AIP mice, respectively. Below the 
images are depicted their respective plot profiles. E, average values for CaSpF, Ca2+ leak, 
Sommese et al. Page 29
Int J Cardiol. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Waves F and SC frequency of myocytes from CD and FRD WT and SR-AIP mice. SR-AIP 
mice were protected from arrhythmias and local SCRE. Data are mean ± SEM. n= 14 to 21 
myocytes from 4 mice per group, *p<0.05 compared with CD WT mice; #p<0.05 compared 
with FRD WT mice.
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